Janssen gets European Commission nod for AKEEGA to treat metastatic castration resistant prostate cancer with BRCA1/2 mutations Ruchika Sharma22 April 2023 11:32 AM ISTThe EC authorisation, which also marks the first worldwide approval for AKEEGA, is based on results of the randomised, double-blind, placebo...
US judge halts most talc lawsuits against Johnson and Johnson Ruchika Sharma21 April 2023 2:15 PM ISTLTL Management argued that allowing litigation against J&J to continue would imperil current settlement efforts.
JnJ talc unit faces skepticism on bankruptcy settlement support Ruchika Sharma12 April 2023 2:43 PM ISTUS: A Johnson & Johnson company on Tuesday defended its second attempt to resolve talc lawsuits in bankruptcy, telling a U.S. judge it can...
Johnson and Johnson talc unit 2nd bankruptcy must be dismissed, cancer victims' lawyers say Ruchika Sharma11 April 2023 2:48 PM ISTUS: Johnson & Johnson’s second attempt to resolve talc lawsuits in bankruptcy should be dismissed as an unprecedented fraud designed to deny...
JnJ unit loses bid to stay in bankruptcy during Supreme Court appeal Ruchika Sharma1 April 2023 3:35 PM ISTUnited States: A Johnson & Johnson company cannot delay a court order dismissing its bankruptcy, a U.S. court said on Friday, despite the...
Johnson and Johson to discontinue late-stage study of RSV vaccine Ruchika Sharma31 March 2023 4:00 PM ISTPfizer and GSK are running a tight race to tap into the RSV vaccine market, which is estimated to be more than $5 billion and could exceed $10 billion...
Big Blow: JnJ loses patent battle of key tuberculosis drug Bedaquiline in India Farhat Nasim24 March 2023 2:50 PM ISTNew Delhi: As the world observes TB day, leading pharma giant Johnson and Johnson (JnJ) has faced a major blow as the Indian Patent Office on Thursday...
Janssen seeks USFDA nod for Niraparib and Abiraterone Acetate Dual-Action Tablet, plus Prednisone to treat patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Gene Mutations Ruchika Sharma2 March 2023 3:15 PM ISTMetastatic castration-resistant prostate cancer characterizes cancer that no longer responds to androgen deprivation therapy and has spread to other...
Johnson & Johnson names Ex-Sanofi Chief Dr John Reed as Executive Vice President, Pharmaceuticals, RnD Ruchika Sharma14 Feb 2023 12:15 PM ISTDr Reed previously served as Executive Vice President, Global Head of Research and Development for Sanofi and brings more than 35 years of biomedical...
Janssen, Global Partners to discontinue Phase 3 Mosaico HIV vaccine trial Ruchika Sharma19 Jan 2023 4:15 PM ISTLeiden: The Janssen Pharmaceutical Companies of Johnson & Johnson, together with a consortium of global partners, has announced the results of an...
Bombay HC permits Johnson & Johnson to manufacture, sell baby powder Dr. Nandita Mohan14 Jan 2023 5:19 PM ISTThe Bombay High Court on Wednesday quashed two orders passed by the Maharashtra government revoking the license of Johnson & Johnson company to...
CDSCO panel opines Johnson and Johnson to submit details of anticancer drug Teclistamab nod in EU, US Roshni Dhar16 Dec 2022 5:20 PM ISTIn response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and 90mg/vial, the...
